Home World News Nivolumab Plus AVD Prolongs PFS in Adolescents and Adults with Advanced-Stage Classic... World News Nivolumab Plus AVD Prolongs PFS in Adolescents and Adults with Advanced-Stage Classic Hodgkin’s Lymphoma By Ogkologos - October 30, 2024 3284 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the S1826 study Source RELATED ARTICLESMORE FROM AUTHOR New on NCI’s Websites for November 2024 A Short-Course of Induction Chemotherapy Followed by Chemoradiotherapy Significantly Improves Survival in Patients with Locally Advanced Cervical Cancer Targeted Therapy, Driven by Comprehensive Genomic Profiling and Molecular Tumour Board, Improves Outcomes In Pretreated Patients with Metastatic Cancer MOST POPULAR A New Study Suggests Screen Time Might Not Be The Worst... November 14, 2019 After Being Told a Lump Was Benign, Teenager Learns She Has... August 14, 2021 Skin cancer death rates in men risen dramatically in the last... July 14, 2022 The Barriers to Care Faced by LGBTQ People With Cancer: An... January 21, 2021 Load more HOT NEWS The Healing Power of Being Outdoors for People With Cancer Fruquintinib Prolongs Survival Compared with Placebo in Heavily Pretreated Patients with... A Short-Course Dose Escalation Strategy Could Improve Ability to Reach Target... Study Links Non-Diet Soda Consumption with a Higher Risk of Death...
